How to Get Losartan in South Dakota

At a glance
- Drug class / Angiotensin II receptor blocker (ARB)
- Approved indications / Hypertension, heart failure, diabetic nephropathy (type 2 DM with proteinuria)
- Typical starting dose / 50 mg once daily (25 mg for volume-depleted patients)
- Telehealth prescribing in SD / Legal for new and established patients
- 503A compounding in SD / Available through licensed SD compounding pharmacies
- SD Medicaid coverage / Not covered as of the current formulary
- Required pre-prescription labs / Basic metabolic panel (BMP), serum creatinine, potassium, eGFR
- Retail cash price (generic) / $10 to $15 per 30 tablets at major SD chains
- Time from consult to medication / As fast as same day for local pickup; 1 to 3 days via mail-order
- Who can prescribe / MD, DO, NP (with prescriptive authority), PA
What Losartan Is and Why South Dakota Patients Use It
Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for three indications: hypertension, reduction of stroke risk in hypertensive patients with left ventricular hypertrophy, and diabetic nephropathy in patients with type 2 diabetes and elevated urine protein [1]. It blocks the AT1 receptor, reducing vascular resistance and lowering blood pressure without the bradykinin-mediated cough associated with ACE inhibitors.
South Dakota has an age-adjusted hypertension prevalence of approximately 32.4% among adults, according to CDC Behavioral Risk Factor Surveillance System data [2]. That places a large share of the state's roughly 900,000 adults in the pool of patients who might benefit from an ARB like losartan.
The LIFE trial (Lancet 2002, N=9,193) compared losartan to atenolol in hypertensive patients with electrocardiographic left ventricular hypertrophy. Losartan reduced the primary composite endpoint of cardiovascular death, myocardial infarction, and stroke by 13% (relative risk 0.87 to 95% CI 0.77 to 0.98, P=0.021) and reduced new-onset diabetes by 25% compared with atenolol [3]. The RENAAL trial (N=1,513) showed losartan 50 to 100 mg daily reduced the risk of doubling serum creatinine, end-stage renal disease, or death by 16% in patients with type 2 diabetes and nephropathy [4].
Losartan is available as 25 mg, 50 mg, and 100 mg oral tablets. The FDA-approved starting dose for hypertension is 50 mg once daily, titrated to 100 mg if needed [1].
How to Get a Losartan Prescription in South Dakota
Getting losartan in South Dakota requires a valid prescription from a licensed prescriber. You have three practical pathways: an in-person visit to a primary care physician or cardiologist, a telehealth consultation with a South Dakota-licensed provider, or an urgent-care walk-in visit for blood pressure evaluation.
South Dakota follows federal DEA scheduling rules for controlled substances, but losartan is not a controlled substance. That distinction matters because it means a prescriber can issue a new losartan prescription via audio-visual telehealth without the additional restrictions that apply to Schedule II to IV drugs [5]. The South Dakota Board of Medical Examiners requires that a valid prescriber-patient relationship be established before a prescription is issued, and a synchronous telehealth visit satisfies that requirement under South Dakota Codified Law 36-4-42 [6].
Step 1. Book a telehealth or in-person appointment. Provide your blood pressure readings (home monitor logs if available), medication history, and any documentation of prior diagnoses such as diabetes or chronic kidney disease.
Step 2. Complete required baseline labs before or immediately after your consultation (see the next section for specifics).
Step 3. The prescriber sends the prescription electronically to a South Dakota pharmacy of your choice, or to a mail-order pharmacy licensed to ship to SD.
Step 4. Pick up at the pharmacy or receive via mail. Generic losartan is available at Walgreens, CVS, Sanford Health pharmacies, Avera pharmacies, and independent pharmacies across Sioux Falls, Rapid City, Aberdeen, and smaller SD communities.
What Labs Are Needed Before Starting Losartan in South Dakota
Prescribers ordering losartan require at minimum a basic metabolic panel (BMP) that includes serum creatinine, blood urea nitrogen, potassium, and an estimated GFR. These values matter because losartan can raise serum potassium and is contraindicated in bilateral renal artery stenosis [1].
The 2023 ACC/AHA Hypertension Guideline recommends baseline urinalysis, BMP, fasting lipid panel, thyroid-stimulating hormone, and an electrocardiogram before initiating antihypertensive therapy in most adults [7]. For patients with diabetes or suspected chronic kidney disease, a spot urine albumin-to-creatinine ratio (UACR) is also standard, since the RENAAL and IDNT trials used UACR as both an enrollment criterion and an efficacy endpoint [4][8].
Potassium deserves specific attention. ARBs block aldosterone release, and baseline hyperkalemia (serum K>5.0 mEq/L) is a relative contraindication. Patients on potassium-sparing diuretics or with an eGFR <30 mL/min/1.73m² need particularly careful monitoring [9]. A repeat BMP at 1 to 2 weeks after initiation and again at 1 to 3 months is standard practice per JNC-8 implementation guidance [10].
Most South Dakota telehealth platforms can order labs through Quest Diagnostics or LabCorp, both of which have draw sites in Sioux Falls, Rapid City, Aberdeen, Watertown, and Mitchell. Results typically return in 24 to 48 hours.
Telehealth Providers in South Dakota That Prescribe Losartan
Telehealth prescribing of losartan in South Dakota is straightforward. State law allows synchronous audio-visual consultations to establish a valid prescriber-patient relationship, and no in-person physical examination is mandated for non-controlled prescriptions such as ARBs [6].
South Dakota-licensed prescribers on platforms such as HealthRX can evaluate blood pressure history, review uploaded lab results, and issue an electronic prescription to your preferred pharmacy during a single visit. Sanford Health and Avera Health, the two dominant health systems in the state, also offer telehealth primary care that can prescribe and manage antihypertensives.
A practical decision framework for South Dakota patients choosing a prescribing pathway:
- No prior diagnosis, no labs on file. Schedule telehealth, order labs first, return for prescription visit. Timeline: 3 to 5 days.
- Existing diagnosis with labs within 6 months. Single telehealth visit. Same-day or next-day prescription. Timeline: under 24 hours.
- Established patient transferring from another state. Transfer existing prescription or provide records; telehealth prescriber confirms labs and issues new SD prescription. Timeline: 1 to 2 days.
- Urgent uncontrolled hypertension (systolic >180 mmHg). Emergency department or urgent care in-person visit is appropriate first contact.
The 2022 AAFP position statement on telehealth affirms that chronic disease management, including hypertension, is appropriate for ongoing telehealth care [11]. Patients in rural South Dakota counties, including Haakon, Ziebach, and Corson, often have no in-person cardiology access within 60 miles, making telehealth the only realistic option for timely ARB initiation.
Losartan Pharmacies in South Dakota: Retail, Mail-Order, and 503A Compounding
Retail pharmacies. Generic losartan (potassium) tablets are on the $4/$10 generics list at Walmart pharmacy locations in South Dakota. CVS and Walgreens charge $10 to $15 for 30 tablets without insurance. GoodRx coupons regularly bring 30-tablet supplies of 50 mg losartan below $8 at Sioux Falls and Rapid City locations.
Mail-order. Major pharmacy benefit managers (Express Scripts, CVS Caremark, OptumRx) ship to South Dakota. A 90-day supply of generic losartan through mail-order often costs less than a single retail 30-day copay under commercial insurance.
503A compounding pharmacies. South Dakota law permits 503A patient-specific compounding. A licensed South Dakota 503A compounding pharmacy may prepare losartan in alternative formulations (oral suspension, for example) for patients with documented medical need, such as dysphagia or pediatric dosing requirements. The compounding pharmacy must be licensed by the South Dakota Board of Pharmacy [12]. Losartan suspensions prepared by 503A pharmacies are not FDA-approved finished products; they require a patient-specific prescription and a prescriber attestation of medical necessity [13].
FDA guidance specifies that 503A compounders may not copy commercially available drugs without a patient-specific reason, and since 25 mg, 50 mg, and 100 mg losartan tablets are commercially available, a suspension would require documented clinical justification [13].
South Dakota Medicaid and Insurance Coverage for Losartan
South Dakota Medicaid does not currently cover losartan under its standard formulary. Patients on SD Medicaid who need an ARB should ask their prescriber about losartan alternatives that are on the SD Medicaid preferred drug list, or ask for a prior authorization (PA) request if losartan is clinically preferred [14].
For commercial insurance, losartan is typically placed on Tier 1 (preferred generic) with a $0 to $10 copay. Medicare Part D formularies almost universally include generic losartan on Tier 1. The 2022 Inflation Reduction Act capped Medicare Part D out-of-pocket costs, further reducing the financial burden for seniors on fixed doses of losartan [15].
Prior authorization for losartan on commercial plans is uncommon given its generic status, but PA may be required for the brand-name Cozaar or for doses above 100 mg. When PA is required, the typical documentation package includes a diagnosis code (ICD-10 I10 for hypertension, N08 for diabetic nephropathy), a recent BMP or CMP with creatinine and potassium values, evidence of a trial or contraindication to ACE inhibitors, and blood pressure logs showing inadequate control on first-line agents.
Dosing, Monitoring, and Safety Essentials for South Dakota Patients
The FDA-labeled dose range for losartan is 25 mg to 100 mg once daily [1]. Patients who are volume- or sodium-depleted (for example, those on diuretics) should start at 25 mg to reduce the risk of symptomatic hypotension. For diabetic nephropathy, the target dose used in RENAAL was 100 mg daily, and that is the dose associated with the 16% reduction in the renal composite endpoint [4].
Key monitoring parameters after initiation:
- Serum creatinine and potassium at 1 to 2 weeks and again at 1 to 3 months [10].
- Blood pressure at each clinical contact; target <130/80 mmHg per the 2023 ACC/AHA guideline for most adults with hypertension and cardiovascular risk [7].
- UACR at 3 to 6 month intervals for patients with diabetic nephropathy to assess proteinuria response [4].
Losartan carries an FDA black-box warning for fetal toxicity. It must not be used during pregnancy [1]. Any South Dakota patient who becomes pregnant while on losartan should contact their prescriber immediately to switch to a pregnancy-compatible antihypertensive such as labetalol or nifedipine.
Drug interactions worth noting: concurrent use of NSAIDs may blunt the antihypertensive effect and increase the risk of acute kidney injury [16]. Combining losartan with aliskiren is contraindicated in patients with diabetes per the FDA label [1]. Potassium supplements and potassium-sparing diuretics increase the risk of hyperkalemia and require close monitoring of serum potassium [9].
Who Can Prescribe Losartan in South Dakota
In South Dakota, losartan may be prescribed by:
- MDs and DOs (licensed by the South Dakota Board of Medical Examiners)
- Nurse practitioners (NPs) with full practice authority. South Dakota is a full-practice-authority state for NPs under SDCL 36-9A, meaning NPs do not require physician supervision to prescribe [17].
- Physician assistants (PAs) with a supervising physician agreement, though South Dakota moved toward reduced oversight requirements for PAs in 2021 legislation [18].
- Clinical pharmacists with prescriptive authority in collaborative practice agreements may adjust doses but typically do not initiate new ARB therapy independently.
Full practice authority for NPs in South Dakota means that telehealth platforms staffed by NPs can independently initiate losartan therapy for appropriate patients without requiring a physician co-signature, which shortens the prescribing timeline considerably.
Transferring a Losartan Prescription to South Dakota
Patients relocating to South Dakota from another state can transfer an existing losartan prescription to any South Dakota retail pharmacy. Federal law and South Dakota pharmacy regulations allow the transfer of a prescription for a non-controlled substance between licensed pharmacies [19]. The receiving pharmacy contacts the original pharmacy directly; you do not need a new prescription for an existing, unexpired refill.
If the original prescription has no remaining refills, a new prescription from a South Dakota-licensed prescriber is required. In that case, a telehealth visit with medical records from the previous prescriber is the fastest path. Most telehealth platforms process transferred-patient visits in 15 to 30 minutes when labs are up to date and prior records are available.
For patients using mail-order pharmacies licensed in other states, confirm that the pharmacy holds a non-resident pharmacy permit from the South Dakota Board of Pharmacy before having a prescription shipped to an SD address [12].
How Long Does It Take to Get Losartan in South Dakota
The timeline depends on your starting point:
- Existing prescription, retail transfer. Pharmacy-to-pharmacy transfer typically completes in 2 to 4 hours. Same-day pickup is standard.
- Telehealth visit, labs already on file. Prescriber can send an e-prescription during or immediately after the visit. Local pharmacy pickup within 1 to 2 hours; mail-order in 1 to 3 business days.
- Telehealth visit, labs needed. Lab draw, 24 to 48-hour result turnaround, then a follow-up consult and prescription. Total timeline: 3 to 5 days.
- New in-person visit. Appointment availability varies. Sanford and Avera primary care in Sioux Falls typically offer appointments within 5 to 10 business days for non-urgent hypertension. Urgent-care same-day visits can initiate therapy faster.
The JNC-8 panel noted that the goal is to reach blood pressure targets within 1 month of initiating therapy in most patients [10]. Delaying prescription access by more than a week due to logistical barriers is clinically meaningful in stage 2 hypertension (systolic ≥140 mmHg), where each 10 mmHg reduction in systolic blood pressure reduces the risk of major cardiovascular events by approximately 20% based on meta-analysis of 123 trials (N=613,815) published in The Lancet [20].
Frequently asked questions
›How do I get a losartan prescription in South Dakota?
›What labs are needed before starting losartan in South Dakota?
›Are there telehealth providers in South Dakota prescribing losartan?
›How long until I receive losartan in South Dakota?
›Can I transfer a losartan prescription to South Dakota?
›Are 503A pharmacies in South Dakota licensed to ship losartan?
›Who can prescribe losartan in South Dakota: MD vs NP vs PA?
›What documentation does prior authorization require in South Dakota?
›Is losartan covered by South Dakota Medicaid?
›What is the usual losartan dose for high blood pressure?
References
- FDA. Cozaar (losartan potassium) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020386s051lbl.pdf
- Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System: hypertension prevalence by state. https://www.cdc.gov/bloodpressure/data-research/facts-stats/index.html
- Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. https://pubmed.ncbi.nlm.nih.gov/11937178/
- Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy (RENAAL). N Engl J Med. 2001;345(12):861-869. https://pubmed.ncbi.nlm.nih.gov/11565518/
- Drug Enforcement Administration. Telemedicine prescribing of controlled substances. https://www.dea.gov/telemedicine
- South Dakota Legislature. SDCL 36-4-42: Telehealth practice standards. https://sdlegislature.gov/Statutes/36-4-42
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
- Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes (IDNT). N Engl J Med. 2001;345(12):851-860. https://pubmed.ncbi.nlm.nih.gov/11565517/
- Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004;351(6):585-592. https://pubmed.ncbi.nlm.nih.gov/15295050/
- James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults (JNC-8). JAMA. 2014;311(5):507-520. https://pubmed.ncbi.nlm.nih.gov/24352797/
- American Academy of Family Physicians. Telehealth position paper. 2022. https://www.aafp.org/about/policies/all/telehealth.html
- South Dakota Board of Pharmacy. Pharmacy licensing and compounding regulations. https://doh.sd.gov/boards/pharmacy/
- FDA. Guidance for industry: Pharmacy compounding of human drug products under section 503A of the Federal Food, Drug, and Cosmetic Act. https://www.fda.gov/media/99590/download
- South Dakota Department of Social Services. Medicaid preferred drug list. https://dss.sd.gov/medicaid/providers/billinginstructions/pharmacy.aspx
- CMS. Inflation Reduction Act and Medicare Part D drug pricing reforms. https://www.cms.gov/inflation-reduction-act
- Loboz KK, Shenfield GM. Drug combinations and impaired renal function: the double jeopardy of NSAIDs and ACE inhibitors or ARBs. Aust Prescr. 2005;28(6):143-145. https://pubmed.ncbi.nlm.nih.gov/16421607/
- South Dakota Legislature. SDCL 36-9A: Advanced practice registered nurse full practice authority. https://sdlegislature.gov/Statutes/36-9A
- South Dakota Legislature. Physician assistant practice act amendments 2021. https://sdlegislature.gov/Statutes/36-4A
- National Association of Boards of Pharmacy. Model State Pharmacy Act and Model Rules: prescription transfer requirements. https://nabp.pharmacy/members/boards-of-pharmacy/
- Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957-967. https://pubmed.ncbi.nlm.nih.gov/26724178/